Viking Therapeutics (VKTX) Net Shares Issued and Repurchased (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Net Shares Issued and Repurchased came in at $910896.0 in Q1 2026, up 82.49% year-over-year from $499145.0 in Q1 2025, and up 38.22% quarter-over-quarter from $659033.0 in Q4 2025.
Powered by 
Analysis
Viking Therapeutics (VKTX) Net Shares Issued and Repurchased (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Net Shares Issued and Repurchased across 13 years of filings, most recently posting $910896.0 for Q1 2026.
- In Q1 2026, Net Shares Issued and Repurchased rose 82.49% year-over-year to $910896.0; the TTM figure through Mar 2026 stood at $910896.0 (up 82.49% YoY), while the FY2025 annual figure was $659033.0, down 45.95% from the prior year.
- Net Shares Issued and Repurchased came in at $910896.0 for Q1 2026 at Viking Therapeutics, up from $659033.0 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.5 million in Q4 2023 to a low of $499145.0 in Q1 2025.
- Average Net Shares Issued and Repurchased over 5 years is $1.0 million, with a median of $1.1 million recorded in 2024.
- Year-over-year, Net Shares Issued and Repurchased tumbled 54.17% in 2025 and jumped 82.49% in 2026.
- Over 5 years, Net Shares Issued and Repurchased stood at $1.1 million in 2022, then surged by 34.17% to $1.5 million in 2023, then declined by 18.12% to $1.2 million in 2024, then tumbled by 45.95% to $659033.0 in 2025, then jumped by 38.22% to $910896.0 in 2026.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $910896.0 in Q1 2026, $659033.0 in Q4 2025, and $499145.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | - |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | - |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 910,896.00 |
| Dec 31, 2025 | 659,033.00 |
| Mar 31, 2025 | 499,145.00 |
| Dec 31, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 1.49 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.11 Mn |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 40,000.00 |
| Jun 30, 2021 | 40,000.00 |
| Mar 31, 2021 | 817,020.00 |
| Dec 31, 2020 | 960,472.00 |
| Mar 31, 2020 | 831,772.00 |
| Dec 31, 2019 | 855,787.00 |
| Mar 31, 2019 | 636,287.00 |
| Dec 31, 2018 | 628,500.00 |
| Mar 31, 2018 | 455,000.00 |
| Dec 31, 2017 | 892,534.00 |
API Access
Viking Therapeutics Net Shares Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-shares-issued-and-repurchased", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();